EMEA-002861-PIP02-20-M03

Key facts

Invented name
Comirnaty
Active substance
Tozinameran
Therapeutic area
Infectious diseases
Decision number
P/0547/2021
PIP number
EMEA-002861-PIP02-20-M03
Pharmaceutical form(s)
Concentrate for solution for injection
Condition(s) / indication(s)
Prevention of Coronavirus disease 2019 (COVID-19)
Route(s) of administration
Intramuscular use
Contact for public enquiries
BioNTech Manufacturing GmbH

Email: pediatric@biontech.de    
Tel. +49 613190847593
 

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

Related content

How useful was this page?

Add your rating
Average
12 ratings
5 ratings
1 rating
6 ratings
104 ratings